STATE STREET CORP - LIXTE BIOTECHNOLOGY HLDGS IN ownership

LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 13 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of LIXTE BIOTECHNOLOGY HLDGS IN
ValueSharesWeighting
Q1 2023$29,843
-18.2%
35,956
-50.0%
0.00%
Q4 2022$36,496
+82.5%
71,912
+100.0%
0.00%
Q3 2022$20,000
-28.6%
35,9560.0%0.00%
Q2 2022$28,000
-34.9%
35,956
+1.3%
0.00%
Q1 2022$43,000
+2.4%
35,5000.0%0.00%
Q4 2021$42,000
-40.0%
35,500
+5.7%
0.00%
Q3 2021$70,000
-31.4%
33,6000.0%0.00%
Q2 2021$102,00033,6000.00%
Other shareholders
LIXTE BIOTECHNOLOGY HLDGS IN shareholders Q1 2022
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 166,667$124,0000.09%
SABBY MANAGEMENT, LLC 99,644$74,0000.05%
Almanack Investment Partners, LLC. 248,084$185,0000.02%
Warberg Asset Management LLC 14,500$11,0000.00%
TWO SIGMA INVESTMENTS, LP 16,948$13,0000.00%
WELLS FARGO & COMPANY/MN 49$00.00%
GEODE CAPITAL MANAGEMENT, LLC 25,794$19,0000.00%
STATE STREET CORP 35,956$28,0000.00%
MORGAN STANLEY 71,054$53,0000.00%
Citadel Advisors 30,063$23,0000.00%
View complete list of LIXTE BIOTECHNOLOGY HLDGS IN shareholders